Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 559.65
-0.367 %
$ 214 B
Market Cap
35.09
P/E
TMO - COST OF REVENUE
Cost of Revenue TMO - Thermo Fisher Scientific Inc.
25.7 B
LAST VALUE
16.47%
2 YEAR CAGR
14.65%
5 YEAR CAGR
13.37%
10 YEAR CAGR